$ADIL News Article - Adial Pharmaceuticals Announces Greater Than 50% of Patients Expected to Complete ONWARD(TM) Phase 3 Trial of AD04 for the Treatment of Alcohol Use Disorder Have Completed the Full 24-Week Treatment Period - Trial Completion Anticipated Q1 2022
https://marketwirenews.com/news-releases/adia...22248.html